Ferrari, NHS and Insider Selling | Palantir Bullets #2

This week's Palantir developments and the crowned “Tweet of the Week.”

Arny Trezzi

and

Emanuele Marabella

Nov 27, 2022

Editor: Emanuele’s Notepad

Hi, I’m Arny 😊 Join more than 760+ fellow Palantir investors spotting asymmetries. If you are new, you can join here. Please hit the heart button if you like today’s article.

Get a 33% discount!

Palantir this week:

Palantir announced an Extraordinary Shareholder Meeting. This is the resolution from the settlement against a lawsuit Palantir received because Class F shares seemed to violate sections of the Delaware Code (where Palantir is incorporated). This meeting focuses only on correcting specifications of the voting power of Class F shares. For instance, the New Certificate would delete the “reasonable best efforts” qualification and will require to be specific on the procedures that lead to decisions. For common shareholders, nothing changes so this is not a reason to worry.

Kris Patel @KrisPatel99

Palantir is doing an amendment of their incorporation. $PLTR community please stop speculating without reading...

Insiders keep selling shares. This is part of their RSU vesting plans. When their RSU get vested they automatically sell a fraction of the shares to cover the related taxes. C-Level people are not selling more shares than those related to tax events. Despite I would love to see executives buying at the current prices, the fact they sell for tax reasons is not negative. It would be worrying if we started seeing massive sales in the open market.

らっち@🇺🇸投資3年生🔮 @racchikabu

$PLTR パランティアのインサイダー売り報告 Shyam Sankar 278,033株($1,998,989.37相当)売却 Glazer David A. 96,662株($694,976.20相当)売却 Jeffrey Buckley 16,911株($121,585.96相当)売却 Taylor Ryan D. 86,415株($621,302.70相当)売却 Cohen Stephen Andrew 358,921株($2,580,554相当)売却

NHS seems to have split the £400mn contract, as activists protest privacy concerns over Palantir being the exclusive provider. Palantir is still set to bid for the £360mn data platform which is the core element of the contract, therefore, the most critical. Paradoxically, Palantir is accused of violating patient privacy, which is exactly what its solutions work against. It seems likely that Palantir will win the £360mn contract as the other bidder is Quantexa, which bids along a consulting consortium, therefore, has a weak offering. However, not capturing 100% of the contract could be enough to manage the complaints of Palantir protesters.
🧙🏼‍♂️ @TheKameroon
$PLTR Is still set to bid for the contract to operate the NHS’s main platform. ft.com/content/a9228c…
8:12 PM ∙ Nov 25, 2022
12Likes2Retweets

Either Square found that 90% of Foundry links are still active. Considering that active links also incorporate pilots, I consider it a good sign. Join
Palantir's Missing Link
to stay updated with link activity!

Either_Square @Either_Square

90.14% of every Palantir Foundry link is *ACTIVE*. That means 9 in every 10 historical links is still up and running... Not too bad! *Substack supporters can access DataBase and see statistics and more info on each codename / link*

Faraday Future, one of Palantir’s SPAC, is almost bankrupt. Palantir sold part of its position in Q3 (previous Bullets).

Drive Tesla 🇨🇦 @DriveTeslaca

Faraday Future has “substantial doubt” about continuing to operate

driveteslacanada.caFaraday Future has “substantial doubt” about continuing to operateFaraday Future has “substantial doubt” about its ability to continue operating, given the company’s current financial situation.

Merck has a new biopharma department operating with Foundry called Serono. As a reminder, Merck is one of Palantir’s biggest clients and the only one already having developed two Open Data Platforms, Athinia (Semiconductors) and Syntropy (Healthcare). These platforms are crucial for Palantir’s future growth (PLTR Platforms Unleash Network Effects).

らっち@🇺🇸投資3年生🔮 @racchikabu

$PLTR Merckの一部門EMD SeronoのTech Lead Data & Analytics (Palantir Foundry)は、AWS と共にFoundryを活用する際に、ベストプラクティスが適用されるように部門を指導する役割があり、新しく設立されたデータオフィスの一員として、リードプロダクトマネージャーと密接に連携。1時間前の新着求人

Mattia Binotto, Scuderia’s Ferrari Principal is leaving after a season of gaffes and missed opportunities. This should not impact Palantir’s partnership with Ferrari, which was expanded just 9 months ago.

Palantir @PalantirTech

Since 2016, @ScuderiaFerrari has used #Palantir Foundry to help drive data-driven decisions, optimizing race car performance. We are excited to expand our agreement and announce Palantir will be an official Team Partner of #ScuderiaFerrari. Learn more: bwnews.pr/3uFxv0t

Related Tech trends/Macro:

M&A activity is standstill due to economic uncertainty, for now. An M&A survey report by Morrison Foerster and Mergermarket highlights how 2023 should be a very strong year: thanks to low valuations, “despite market volatility, global dealmakers continue to prioritise technology acquisitions, especially in heated sectors like artificial intelligence and machine learning.” A renewed interest in the tech space should support valuations.

Maverick Equity Research 🇺🇦✌️🇺🇦 @Maverick_Equity

The US Mergers & Acquisitions Market Index via FactSet

FED officials expect to switch to smaller interest rate increases “soon.” Interest rates are one of the major causes that keep the Cloud Sector valuation low (Palantir Valuation Tracker). Therefore, any signals that the interest rate hikes would be less intense or that the FED could pivot would be enormously supportive for “growth stocks” like Palantir. The central bank’s next interest rate decision is Dec. 14.

Rihard Jarc @RihardJarc

The key thing in the FED minutes: Participants agreed a slower rate hike pace would allow the FOMC to better assess progress given the uncertain lags associated with monetary policy.

VC investments are collapsing. This is a contrarian indicator, hinting that the market has deflated and therefore, the euphoria has translated into depression. For true investors, depression means an opportunity to buy at good prices.